Philadelphia Inquirer: High out-of-pocket costs may place oral cancer medications out of reach

“Many cancer patients are foregoing prescribed oral treatments because of high out-of-pocket costs, a new study led by University of Pennsylvania researchers suggests. Using a national database of Medicare and private health insurance claims in 2014-15, the researchers looked at whether patients’ unreimbursed expenses were a deterrent to filling prescriptions for 38 therapies given in pill form…” Read more at the Philadelphia Inquirer, Health Day and PatientEngagementHIT.